Kaplan Gilla
- SEC CIK
- 0001247024
In the past year, 1 open-market sale filing worth $528.5K and no purchases.
Current role at each company
- AVTX Avalo Therapeutics, Inc.Directoras of Jun 4, 2026
- TYRA Tyra Biosciences, Inc.Directoras of Mar 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $528.5K
- 1 filing
- Net
- −$528.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kaplan Gilla as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TYRA Tyra Biosciences, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 (view filing) | Jun 12-16 | 4 days | Kaplan GillaDirector | SSale | −51.8K | $10.32 | −$534.7K | −57.8%37.8K after | 3 lots |
| Jun 20, 2025 (view filing) | Jun 17-18 | 3 days | Kaplan GillaDirector | SSale | −9.58K | $9.78 | −$93.7K | −25.3%28.2K after | 2 lots |
| Mar 27, 2026 (view filing) | Mar 25 | 2 days | Kaplan GillaDirector | SSale | −14.3K | $36.97 | −$528.5K | −33.6%28.2K after |